Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synopsys Inc. filings document the regulatory record for a Nasdaq-listed engineering software company whose common stock trades under SNPS. The company’s disclosures cover operating and financial results, capital allocation actions such as stock repurchase authorizations and accelerated share repurchase agreements, and material-event reports tied to governance, executive roles, and organizational changes.
Proxy and annual meeting materials describe board elections, shareholder voting matters, executive compensation, equity incentive plan approvals, and corporate governance practices. Recent Form 8-K filings also document restructuring actions following the completed Ansys acquisition, amendments to prior governance disclosures, registered common stock details, exhibits, and risk-oriented statements associated with forward-looking business actions.
Synopsys Inc. Chief Revenue Officer Michael Ellow reported routine equity compensation activity involving restricted stock units and related tax withholding. On 2026-06-15, 5,128 restricted stock units converted into an equal number of shares of common stock in two installments of 1,080 and 4,048 units.
To cover tax withholding obligations tied to this vesting, the company retained 2,543 shares at a price of $454.38 per share, as approved by the Compensation Committee. After these transactions, Ellow holds 2,041 shares of Synopsys common stock directly and 16 shares indirectly through a family trust, along with 26,713 remaining restricted stock units.
Synopsys Inc. general counsel and corporate secretary Janet Lee reported routine equity compensation activity involving restricted stock units. On 2026-06-15, 540 restricted stock units converted into 540 shares of common stock, reflecting a scheduled vesting.
On the same date, 235 common shares were withheld by Synopsys at a price of $454.38 per share to satisfy Ms. Lee’s tax withholding obligations, as approved by the Compensation Committee. After these transactions, she directly held 15,582 shares of common stock and 2,698 restricted stock units.
Synopsys deputy CFO and chief accounting officer Sudhindra Kankanwadi reported routine equity compensation activity involving restricted stock units. On June 15, 2026, 720 restricted stock units converted into 720 shares of Synopsys common stock as part of a scheduled vesting.
Of these shares, 249 were retained by Synopsys to cover the related tax withholding obligations, as approved by the Compensation Committee, leaving a net 471 shares effectively added to his directly held common stock. Following these transactions, he directly holds 22,690 shares of common stock and 3,597 restricted stock units.
Synopsys CFO Shelagh Glaser reported routine equity compensation activity involving restricted stock units. On June 15, 2026, 1,259 restricted stock units converted into the same number of shares of Synopsys common stock, reflecting a scheduled vesting event. In connection with this vesting, 436 shares of common stock were retained by Synopsys at a price of $454.38 per share to satisfy tax withholding obligations approved by the Compensation Committee, rather than being sold in the open market. Following these transactions, Glaser directly owned 1,452 shares of common stock and indirectly held 14,358 shares through a trust.
Synopsys Inc. director and president/CEO Ghazi Sassine exercised equity awards and sold shares in a pre-planned transaction. On 2026-06-15, he exercised options and restricted stock units to acquire a total of 17,913 shares of common stock, including 14,603 shares from non-qualified stock options at an exercise price of $135.88 per share and 3,310 shares from restricted stock units that convert one-for-one into common stock.
On the same date, he sold 14,603 shares of common stock in open-market transactions at a weighted average price of $458.962 per share under a Rule 10b5-1 trading plan adopted on September 19, 2025, and 1,492 shares were withheld by the company to cover tax obligations related to RSU vesting. Following these transactions, he holds 75,020 shares of Synopsys common stock directly.
Synopsys executive chair Aart de Geus reported routine equity compensation activity involving restricted stock units (RSUs). On 2026-06-15, 449 RSUs converted into the same number of common shares, reflecting a scheduled vesting event.
To cover related tax withholding obligations, 156 common shares were retained by the company at a price of $454.38 per share, as approved by the Compensation Committee. Following these transactions, de Geus directly owned 120,421 shares of Synopsys common stock and held 2,244 RSUs, plus additional indirect holdings through a partnership and a family trust.
Synopsys CFO Shelagh Glaser reported an open-market sale of 3,394 shares of Common Stock at a weighted average price of about $450.02 per share, executed through a trust. The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026. After the sale, Glaser indirectly held 14,358 shares through the Karl and Shelagh Glaser Revocable Trust and directly held 629 shares. A footnote also describes a prior transfer of 17,752 shares into this revocable trust, noted as exempt under Rule 16a-13.
Synopsys Inc.'s General Counsel and Corporate Secretary, Janet Lee, reported routine equity compensation activity involving restricted stock units. She exercised 699 restricted stock units into the same number of common shares, while 304 common shares were retained by the company to satisfy tax withholding obligations approved by the Compensation Committee. After these transactions, she holds 15,581 shares of common stock directly and 2,097 restricted stock units, which each convert into one share of Synopsys common stock as they continue to vest over time.